AIM ImmunoTech is trading at $0.23 (+6.28%) with no clear company-specific catalyst identified for the August 17, 2026 move.
- Recent second-quarter results and DURIPANC updates predate today’s session.
- The broader market is nearly flat, while pre-market activity showed 297,318 shares traded at $0.24, indicating notable early interest.
- The move remains speculative and may reflect short-term trading rather than a confirmed fundamental development.